Mary Yaroshevsky-Glanville
Director/Board Member at Biotech Employee Development Coalition
Network origin in Mary Yaroshevsky-Glanville first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ.
19
| Subsidiary | Pharmaceuticals: Major | 19 |
1322256 Alberta Ltd.
 1322256 Alberta Ltd. Pharmaceuticals: MajorHealth Technology Inex Pharmaceuticals Corporation is a Canadian biopharmaceutical company developing and commercializing proprietary drugs and drug delivery systems to improve the treatment of cancer.
2
| Extinct | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mary Yaroshevsky-Glanville via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Advent International LP
 Advent International LP Investment ManagersFinance Advent International LP (Advent) is an independent private equity firm founded in 1984 by Henry H. Haight. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing General Counsel | |
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Director/Board Member Corporate Officer/Principal | |
| ACURA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Chairman | |
| BIOGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Chief Executive Officer | |
| VANDA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Founder | |
Entelos, Inc.
 Entelos, Inc. Information Technology ServicesTechnology Services Entelos, Inc. develops predictive computer models of human disease. Its solutions include mechanism-based, mathematical models; virtual patients, populations; biosimulation software and biosimulation expertise. The company was founded in 1996 and is headquartered in San Mateo, CA. | Information Technology Services | Director/Board Member | |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Pharmaceuticals: Generic | Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| TRACON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Care Capital LLC
 Care Capital LLC Investment ManagersFinance Care Capital LLC (care capital) is a venture capital firm founded in 2001 by Jan Leschly and David Ramsay. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Private Equity Investor | |
Novartis Pharma Schweiz AG
 Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Taconic Biosciences GmbH
 Taconic Biosciences GmbH Miscellaneous Commercial ServicesCommercial Services Taconic Biosciences GmbH provides research in genetics and functional genomics. It specializes in the generation of genetic models for biomedical research and testing. The company was founded on October 5, 2001 and is headquartered in Leverkusen, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
| University of British Columbia | College/University | Masters Business Admin Undergraduate Degree | |
| State University of New York at Buffalo | College/University | Undergraduate Degree Doctorate Degree | |
| University of Massachusetts | College/University | Doctorate Degree Director/Board Member | |
| University of New Hampshire | College/University | Undergraduate Degree | |
| University of the Sciences in Philadelphia | College/University | Director/Board Member | |
Novartis Venture Funds
 Novartis Venture Funds Investment ManagersFinance Novartis Venture Funds (NVF) is a venture capital firm with headquarters in Basel, Switzerland and an additional office in Cambridge, MA. The firm was founded in 1996. NVF is a subsidiary of Novartis AG (VX: NOVN) and was created following the 1996 merger of Ciba-Geigy and Sandoz. | Investment Managers | Chairman | |
Clinical Development Capital LLC
 Clinical Development Capital LLC Finance/Rental/LeasingFinance Clinical Development Capital LLC (CDC) provides funding for ethical drug clinical trials in return for contingent milestone payments and drug royalties. The company is headquartered in Princeton, NJ | Finance/Rental/Leasing | Chief Executive Officer | |
Novartis Bioventure Fund
 Novartis Bioventure Fund Investment ManagersFinance Novartis Bioventure Fund focuses on companies operating in the field of life science technology. The geographical focus includes the US, Canada, UK and Switzerland. The fund invests in biotechnology, pharmaceuticals and medical device products. It invests in all stages of financing and also invests in mezzanine transactions. | Investment Managers | Founder | |
| Inoteck, Inc. | Chairman | ||
Symphony Evolution, Inc.
 Symphony Evolution, Inc. Pharmaceuticals: MajorHealth Technology Symphony Evolution, Inc. engages in the manufacture of biopharmaceutical drugs. It develops therapeutics to treat cancer and diabetic nephropathy. The company was founded on October 19, 2006 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Director/Board Member | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Chief Executive Officer | |
| Fondation Santé | Director/Board Member | ||
| REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The University of North Carolina at Charlotte | College/University | Doctorate Degree Doctorate Degree | |
| TRAVERE THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Chairman Founder | |
| PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Octave Bioscience, Inc.
 Octave Bioscience, Inc. Medical/Nursing ServicesHealth Services Octave Bioscience, Inc. operates as an early-stage diagnostics company which provides healthcare services. It focuses on neurodegenerative diseases and conditions. The company was founded by William A. Hagstrom in 2014 and is headquartered in Menlo Park, CA. | Medical/Nursing Services | Director/Board Member | |
| DECIBEL THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chairman | |
| CONTINEUM THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Chief Executive Officer | |
Notch Therapeutics, Inc.
 Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | Pharmaceuticals: Other | Chief Executive Officer | |
Shoreline Biosciences, Inc.
 Shoreline Biosciences, Inc. BiotechnologyHealth Technology Shoreline Biosciences, Inc. engages in biotechnology business activities. The company is headquartered in La Jolla, CA. | Biotechnology | Founder Founder | |
Orum Therapeutics USA, Inc.
 Orum Therapeutics USA, Inc. BiotechnologyHealth Technology Part of Orum Therapeutics, Inc., Orum Therapeutics USA, Inc. is a biotechnology company that develops tumor-directed targeted protein degraders. The private company is based in Cambridge, MA. The company was founded in 2016 by Sung Joo Lee. Sung Joo Lee has been the CEO since 2016. | Biotechnology | Director/Board Member |
Statistics
International
| United States | 40 |
| United Kingdom | 4 |
| Switzerland | 4 |
| Canada | 4 |
| Germany | 2 |
Sectoral
| Health Technology | 28 |
| Finance | 7 |
| Commercial Services | 7 |
| Consumer Services | 7 |
| Technology Services | 2 |
Operational
| Director/Board Member | 158 |
| Corporate Officer/Principal | 53 |
| Chairman | 39 |
| Independent Dir/Board Member | 33 |
| Founder | 30 |
Most connected contacts
| Insiders | |
|---|---|
| Argeris Karabelas | 42 |
| Carol Gallagher | 39 |
| George Scangos | 33 |
| Steven Holtzman | 28 |
| Marios Fotiadis | 25 |
| Douglas Williams | 25 |
| Charles M. Cohen | 21 |
| Mark Foletta | 18 |
| David Main | 17 |
| Michael J. Kamdar | 13 |
| Larry C. Fritz | 11 |
| Carmine Stengone | 11 |
| James L. Freddo | 11 |
| James T. Glover | 9 |
| Casey Logan | 8 |
- Stock Market
- Insiders
- Mary Yaroshevsky-Glanville
- Company connections